Suzetrigine, a Selective Pain Signal Inhibitor of NaV1.8 Shows Proof-of-concept for Treatment of Painful Diabetic Peripheral Neuropathy (S11.002)
Roy Freeman, Charles E. Argoff, Robert H. Dworkin, Richard Rauck et al.
Citations
4 citations
Journal
Neurology
Topics
Pain Mechanisms and Treatments
Field-Weighted Citation Impact (FWCI)
4.66
article
Suzetrigine, a Selective Pain Signal Inhibitor of NaV1.8 Shows Proof-of-concept for Treatment of Painful Diabetic Peripheral Neuropathy (S11.002)
Roy Freeman, Charles E. Argoff, Robert H. Dworkin, Richard Rauck, Simon Tian, Carmen Bozic, Xiaopeng Miao, Hannah Bouldin Olivet
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
NeurologyVol. 104(7_Supplement_1)
Institutions
Hadassah Medical Center (IL), Carolinas Pain Institute (US), University of Rochester (US), Vertex Pharmaceuticals (United States) (US), Albany Medical Center Hospital (US)